Production (Stage)
PDS Biotechnology Corporation
PDSB
$1.69
$0.138.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.98M | 41.69M | 49.75M | 57.73M | 66.63M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.49M | 3.36M | 2.38M | 2.43M | 2.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 42.47M | 45.05M | 52.13M | 60.16M | 68.69M |
|
|
|||||
| Total Current Assets | 42.47M | 45.05M | 52.13M | 60.16M | 68.69M |
| Net Property, Plant & Equipment | 289.10K | 304.20K | 319.30K | 334.50K | 320.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.27M | -- | -- | -- | -- |
| Total Assets | 47.03M | 45.36M | 52.45M | 60.50M | 69.01M |
|
|
|||||
| Total Accounts Payable | 2.86M | 1.68M | 1.30M | 3.25M | 6.00M |
| Total Accrued Expenses | 2.85M | 2.84M | 4.48M | 1.95M | 1.71M |
| Short-term Debt | 12.50M | 12.50M | 12.50M | 10.42M | 7.29M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 59.60K | 61.10K | 59.70K | 58.40K | 57.10K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.27M | 17.09M | 18.34M | 15.67M | 15.06M |
|
|
|||||
| Total Current Liabilities | 18.27M | 17.09M | 18.34M | 15.67M | 15.06M |
| Long-Term Debt | 6.35M | 9.20M | 12.03M | 13.81M | 16.65M |
| Short-term Debt | 12.50M | 12.50M | 12.50M | 10.42M | 7.29M |
| Capital Leases | 48.70K | 61.90K | 77.70K | 93.10K | 108.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.67M | 26.35M | 30.45M | 29.58M | 31.82M |
|
|
|||||
| Common Stock & APIC | 212.96M | 201.12M | 196.16M | 194.35M | 192.29M |
| Retained Earnings | -190.60M | -182.11M | -174.16M | -163.43M | -155.10M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.36M | 19.00M | 22.00M | 30.92M | 37.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.36M | 19.00M | 22.00M | 30.92M | 37.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.36M | 19.00M | 22.00M | 30.92M | 37.18M |
|
|
|||||